Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform committed to bringing science-backed benefits to all and reframing the psychedelic conversation, was featured in the latest episode of The Bell2Bell Podcast. Among other highlights of the interview, Delic CEO Matt Stang discussed the company’s network of businesses and the impact psychedelic research is having on the treatment of mental health. “We feel that the time is right now. The mental health crisis is sweeping not only this country but the world,” Delic Holdings CEO Matt Stang stated in the interview. “Last year, in America, we had four-times the highest amount of suicides ever. People are dying. People are hurting, and there are no good methods in the current toolbox of medical technology. At Meet Delic, our giant psychedelic wellness event, one of the doctors that was on our panels said the thing that’s so exciting with psychedelics is that there are curative numbers – not treatment numbers.”
To listed to the full interview, visit https://podcast.bell2bell.com.
To view the full press release, visit https://ibn.fm/1c2Nt
About Delic Holdings
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, including Ketamine Infusion Centers and Ketamine Wellness Centers; the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses. For more information, visit the company’s website at www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire is part of the InvestorBrandNetwork.